| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3 | 100 | 2,830 | $80 | $3.8M |
| J9271 | Injection, pembrolizumab, 1 mg | 8 | 10 | 270 | $3,820 | $2.9M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 3 | 110 | 5,950 | $270 | $2.6M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 13 | 230 | 5,440 | $90 | $1.8M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 11 | 230 | 6,220 | $100 | $1.8M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 18 | 190 | 5,130 | $100 | $1.8M |
| 77412 | The provider delivers radiation therapy at level 3 complexity. This includes photon therapy delivered to multiple isocenters, photon therapy with active motion management, total skin electron… | 6 | 10 | 1,470 | $400 | $1.2M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 10 | 140 | 2,830 | $150 | $1.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 15 | 100 | 1,940 | $70 | $1M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7 | 20 | 190 | $1,670 | $956.2K |